China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 16.02
-0.05 (-0.31%)
Sep 4, 2026, 3:00 PM CST
SHA:600062 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 10,801 | 11,001 | 11,212 | 11,310 | 9,625 | 9,112 |
Revenue Growth | -2.68% | -1.88% | -0.87% | 17.50% | 5.64% | 7.14% |
Gross Profit Gross Profit Growth | 6,108 | 6,341 | 6,380 | 6,406 | 5,318 | 5,064 |
Operating Income Operating Income Growth | 1,596 | 1,706 | 1,641 | 1,725 | 1,237 | 1,034 |
Net Income Net Income Growth | 1,613 | 1,647 | 1,628 | 1,670 | 1,180 | 935.69 |
Earnings Per Share EPS Growth | 1.56 | 1.59 | 1.58 | 1.63 | 1.14 | 0.90 |
EPS Growth | 3.05% | 0.57% | -2.87% | 43.09% | 27.06% | -6.91% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Non-Infusion Non-Infusion Growth | 8,460 | 8,181 | 8,119 | 7,030 | 6,497 |
Offset of Business Segment Offset of Business Segment Growth | -222.69 | -161.28 | -120.97 | -92.76 | -94.27 |
Infusion Infusion Growth | 2,763 | 3,192 | 3,312 | 2,688 | 2,709 |
Total Total Growth | 11,001 | 11,212 | 11,310 | 9,625 | 9,112 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,774 | 2,415 | 2,851 | 3,462 | 2,831 | 3,638 |
Total Debt Total Debt Growth | 1,123 | 1,211 | 1,234 | 322.16 | 289.61 | 58.02 |
Net Cash (Debt) Net Cash Growth | 1,651 | 1,204 | 1,616 | 3,140 | 2,541 | 3,580 |
Net Cash Growth | 23.84% | -25.52% | -48.52% | 23.55% | -29.00% | 9.73% |
Net Cash Per Share Net Cash Per Share Growth | 1.60 | 1.16 | 1.57 | 3.06 | 2.45 | 3.43 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,434 | 1,490 | 1,825 | 1,859 | 1,416 | 1,341 |
Capital Expenditures CapEx Growth | -612.62 | -619.63 | -637.5 | -614.31 | -526.6 | -491.67 |
Free Cash Flow Free Cash Flow Growth | 821.54 | 869.88 | 1,188 | 1,245 | 889.57 | 849.25 |
Free Cash Flow Growth | -7.60% | -26.75% | -4.59% | 39.93% | 4.75% | -16.09% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.55% | 57.64% | 56.91% | 56.64% | 55.25% | 55.57% |
Operating Margin | 14.77% | 15.51% | 14.64% | 15.26% | 12.85% | 11.35% |
Pretax Margin | 16.71% | 17.37% | 16.65% | 17.12% | 14.91% | 12.31% |
Profit Margin | 14.94% | 14.97% | 14.52% | 14.77% | 12.26% | 10.27% |
FCF Margin | 7.61% | 7.91% | 10.59% | 11.01% | 9.24% | 9.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.479 | 0.479 | 0.471 | 0.257 | 0.578 | 0.480 |
Dividend Per Share Growth | 1.70% | 1.70% | 83.27% | -55.54% | 20.42% | 65.52% |
Dividend Yield | 2.98% | 2.68% | 2.50% | 1.48% | 3.51% | 4.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.27 | 11.47 | 12.49 | 11.37 | 15.49 | 14.91 |
Forward PE | 9.37 | 10.36 | 11.03 | 12.46 | 15.32 | 11.70 |
P/FCF Ratio | 20.14 | 21.71 | 17.11 | 15.26 | 20.55 | 16.42 |
PS Ratio | 1.53 | 1.72 | 1.81 | 1.68 | 1.90 | 1.53 |